Dr Marc Mansour has stepped down as CEO of Halifax-based Immunovaccine Inc after 14 years. Mansour will be replaced in an acting capacity while the firm conducts a search for his replacement. Acting CEO Frederic Ors joined Immunovaccine last year from Medicago Inc (now a subsidiary of Mitsubishi) with responsibility for licencing, intellectual property and communications....